Brief: Biocartis Group Announces Launch Of First Assay Developed With New Idylla™ Flex Technology
09/02/2023 06:10
Feb 9 (Reuters) - Biocartis Group NV BCART.BR :
* BIOCARTIS ANNOUNCES LAUNCH OF FIRST ASSAY DEVELOPED WITH
NEW
IDYLLA™ FLEX TECHNOLOGY
Source text for Eikon: ID:nGNE5pPR8d
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies